Last SFr.45.00 CHF
Change Today 0.00 / 0.00%
Volume 0.0
ABT On Other Exchanges
Symbol
Exchange
New York
Mexico
SIX Swiss Ex
London
Sao Paulo
Frankfurt
As of 11:43 AM 12/23/14 All times are local (Market data is delayed by at least 15 minutes).

abbott laboratories (ABT) Snapshot

Open
SFr.45.00
Previous Close
SFr.45.00
Day High
--
Day Low
--
52 Week High
12/2/14 - SFr.43.05
52 Week Low
04/2/14 - SFr.33.98
Market Cap
67.8B
Average Volume 10 Days
0.0
EPS TTM
--
Shares Outstanding
1.5B
EX-Date
01/13/15
P/E TM
--
Dividend
SFr.0.96
Dividend Yield
1.77%
Current Stock Chart for ABBOTT LABORATORIES (ABT)

abbott laboratories (ABT) Details

Abbott Laboratories manufactures and sells health care products worldwide. Its Established Pharmaceutical Products segment offers branded generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome, intrahepatic cholestasis or depressive symptoms, gynecological disorders, dyslipidemia, hypertension, hypothyroidism, pain, fever, and inflammation; and regulates physiological rhythm of the colon, as well as provides hormone replacement therapy and anti-infective and influenza vaccines. The company’s Diagnostic Products segment provides diagnostic systems and tests, such as immunoassay and clinical chemistry systems; assays for screening and diagnosis for drugs of abuse, cancer, therapeutic drug monitoring, fertility, and physiological and infectious diseases; hematology systems and reagents; genomic-based tests; informatics and automation solutions; and diagnostic systems and tests for blood analysis, as well as instruments that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detects and measures infectious agents. Its Nutritional Products segment offers pediatric and adult nutritional products, such as various forms of prepared infant and follow-on formula. The company’s Vascular Products segment provides coronary, endovascular, vessel closure, and structural heart devices for the treatment of vascular diseases. Abbott Laboratories also offers blood glucose and glucose monitoring systems, test strips, and data management software and accessories for people with diabetes; and medical devices for the eye, such as cataract surgery, LASIK surgery, and contact lens care and dry eye products. The company primarily serves retailers, wholesalers, hospitals, health care facilities, laboratories, physicians’ offices, and government agencies. It has strategic alliance with Fonterra Co-operative Group Ltd. The company was founded in 1888 and is headquartered in Abbott Park, Illinois.

69,000 Employees
Last Reported Date: 02/21/14
Founded in 1888

abbott laboratories (ABT) Top Compensated Officers

Chairman, Chief Executive Officer and Chairma...
Total Annual Compensation: $1.9M
Chief Financial Officer and Executive Vice Pr...
Total Annual Compensation: $969.7K
Executive Vice President, General Counsel and...
Total Annual Compensation: $650.0K
Executive Vice President of Diagnostic Produc...
Total Annual Compensation: $614.6K
Executive Vice President of Corporate Develop...
Total Annual Compensation: $629.5K
Compensation as of Fiscal Year 2013.

abbott laboratories (ABT) Key Developments

AB-Biotics Agrees Distribution Deal with Abbott for I3.1 Probiotic in Spain

AB-Biotics has finalised a commercial agreement with Abbott Pharmaceuticals (US) to distribute, promote, and market I3.1 probiotic (a strain that targets bloating, gas formation, and pain). Abbott will handle the exclusive promotion of the I3.1 probiotic in Spain, while the Spanish biotechnology firm focuses on R&D and commercialising its personalised medical product pipeline. AB-Biotics has been expanding its system of granting licensing agreements with other companies since 2012. However, the tie-up with Abbott Pharmaceuticals marks the first licensing agreement for I3.1 probiotic in Europe.

Abbott Laboratories(NYSE:ABT) added to S&P 500 Growth Index

Abbott Laboratories(NYSE:ABT) added to S&P 500 Growth Index

Abbott Announces Quarterly Cash Dividend, Payable on Feb. 13, 2015

The board of directors of Abbott increased the company's quarterly common dividend to $0.24 per share from $0.22 per share. The cash dividend is payable on Feb. 13, 2015, to shareholders of record at the close of business on Jan. 15, 2015.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ABT:SW SFr.45.00 CHF 0.00

ABT Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Actavis plc $257.09 USD +2.89
Danaher Corp $86.73 USD -0.06
Eli Lilly & Co $70.39 USD +0.23
Novo Nordisk A/S kr260.80 DKK -6.40
Thermo Fisher Scientific Inc $127.67 USD +0.88
View Industry Companies
 

Industry Analysis

ABT

Industry Average

Valuation ABT Industry Range
Price/Earnings 35.9x
Price/Sales 3.1x
Price/Book 3.0x
Price/Cash Flow 25.4x
TEV/Sales 2.5x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ABBOTT LABORATORIES, please visit www.abbott.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.